This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Durgut, K. Articles by Solak, H. Search for Related Content PubMed PubMed Citation Articles by Durgut, K. Articles by Solak, H. Social Bookmarking                   What's this?

The cerebroprotective effects of pentoxifylline and aprotinin during cardiopulmonary bypass in dogs

Department of Cardiovascular Surgery, Meram School of Medicine, University of Selcuk, Konya, Turkey, kdurgut{at}selcuk.edu.tr

Kemalettin Hosgor

Department of Cardiovascular Surgery, Meram School of Medicine, University of Selcuk, Konya, Turkey

Niyazi Gormus

Department of Cardiovascular Surgery, Meram School of Medicine, University of Selcuk, Konya, Turkey

Ufuk Ozergin

Department of Cardiovascular Surgery, Meram School of Medicine, University of Selcuk, Konya, Turkey

Hasan Solak

Department of Cardiovascular Surgery, Meram School of Medicine, University of Selcuk, Konya, Turkey

Objective: The purpose of this study was to investigate the cerebroprotective effects of pentoxifylline (PNX) and aprotinin in dogs using cardiopulmonary bypass (CPB).

Materials and methods: Eighteen clinically healthy dogs were divided into three groups: Group 1 (control, n = 6), Group 2 (PNX, n = 6), and Group 3 (aprotinin, n = 6). PNX was administered at a dose of 300 mg/day in Group 2 three days before the operation and during the operation. Half a million IU aprotinin were added to the prime solution and 500 000 IU were transfused via a central venous jugular catheter preoperatively in Group 3. Blood samples were taken from the central jugular vein before and after CPB and interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-), and S100ß protein were measured. Gliosis was investigated histopathologically in cerebral cortex biopsy samples under light microscopy.

Results: The preoperative results of IL-6, TNF-, and S100ß protein values were found to be significantly higher (p < 0.001) when compared with postoperative values. This significant difference was observed in the same parameters between Groups 1 and 2, and 1 and 3 (p < 0.001). There was no significant difference between Groups 2 and 3. Comparison between pre- and postoperative levels of IL-6 and TNF- for Group 2 and Group 3 revealed statistically significant differences (p < 0.001), whereas S100ß protein levels did not. Histopathological examinations showed significant differences between the control group and PNX and aprotinin, and between aprotinin and PNX groups (p < 0.001).

Conclusion: PNX and aprotinin might be useful in order to reduce postoperative cerebral damage in patients undergoing cardiac surgery with CPB.

Perfusion, Vol. 19, No. 2, 101-106 (2004)
DOI: 10.1191/0267659104pf724oa


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. D. McEvoy, S. T. Reeves, J. G. Reves, and F. G. Spinale Aprotinin in Cardiac Surgery: A Review of Conventional and Novel Mechanisms of Action Anesth. Analg., October 1, 2007; 105(4): 949 - 962. [Abstract] [Full Text] [PDF]

				P. J. Hess Jr. Systemic inflammatory response to coronary artery bypass graft surgery Am. J. Health Syst. Pharm., September 15, 2005; 62(18_Supplement_4): S6 - S9. [Abstract] [Full Text] [PDF]